Fusco et al. [79] demonstrated negativity for MMR by IHC (MLH1, MSH2, MSH6, and PMS2) to be 17% homogeneous and 12% heterogeneous in a cohort of 444 breast cancers. The gene discussed is MRC1; the disease is breast cancer.